University of California San Francisco
Helen Diller Family Comprehensive Cancer Center
John P. Roberts, MD, FACS

John P. Roberts, MD, FACS

Professor, Department of Surgery, and Chief, Division of Transplantation, UCSF

Cancer Center Program Memberships

Non-aligned

Education

Stanford University, Palo Alto, CA, BS, 1976, Biology
University of California, San Diego, CA, MD, 1980, Medicine
University of Washington, Seattle, Surgery Resident, 1980-83
Cornell University, New York, Research Fellow, 1983-85
University of Washington, Seattle, Surgery Resident, 1985-86
University of Minnesota, Minneapolis, Transplant Fellow, 1986-87


Professional Experience

  • 1988-1993
    University of California San Francisco, Assistant Professor
  • 1993-1997
    University of California San Francisco, Associate Professor
  • 1995-present
    California Pacific Medical Center, San Francisco, Surgical Director, Liver Transplant Department
  • 1997-present
    University of California San Francisco, Professor
  • 1999-present
    University of California San Francisco, Chief, Transplant Service

Honors & Awards

  • 1991
    Chief Resident Teaching Award, Department of Surgery, UCSF
  • 1992
    Chief Resident Teaching Award, Department of Surgery, UCSF

Selected Publications

  1. Mehta N, Dodge JL, Hirose R, Roberts JP, Yao FY. Increasing Liver Transplant Waitlist Dropout for Hepatocellular Carcinoma with Widening Geographical Disparities: Implications for Organ Allocation. Liver Transpl. 2018 Aug 01.
    View on PubMed
  2. Manuel SP, Roberts JP, Bakhtary S. Preoperative autologous blood collection in adult living liver donors: Are we wasting donor blood and increasing exposure to risk? Transplantation. 2018 Jun 26.
    View on PubMed
  3. Samoylova ML, Mehta N, Roberts JP, Yao FY. Predictors of ultrasound failure to detect hepatocellular carcinoma. Liver Transpl. 2018 May 21.
    View on PubMed
  4. Lai JC, Covinsky KE, Dodge JL, Boscardin WJ, Segev DL, Roberts JP, Feng S. Reply (to LTE HEP-17-2332). Hepatology. 2018 Jan 29.
    View on PubMed
  5. Giard JM, Mehta N, Dodge JL, Roberts JP, Yao FY. Alpha-fetoprotein Slope >7.5 ng/ml/month Predicts Micro-vascular Invasion and Tumor Recurrence after Liver Transplantation for Hepatocellular Carcinoma. Transplantation. 2018 Jan 17.
    View on PubMed
  6. Mehta N, Guy J, Frenette CT, Dodge JL, Osorio RW, Minteer WB, Roberts JP, Yao FY. Excellent Outcomes of Liver Transplantation Following Down-Staging of Hepatocellular Carcinoma to Within Milan Criteria: A Multicenter Study. Clin Gastroenterol Hepatol. 2017 Nov 23.
    View on PubMed
  7. Shaw BI, Burdine LJ, Braun HJ, Ascher NL, Roberts JP. A Formula to Calculate Standard Liver Volume Using Thoracoabdominal Circumference. Transplant Direct. 2017 Dec; 3(12):e225.
    View on PubMed
  8. Mehta N, Dodge JL, Roberts JP, Hirose R, Yao FY. Misdiagnosis of hepatocellular carcinoma in patients receiving no local-regional therapy prior to liver transplant: An analysis of the Organ Procurement and Transplantation Network explant pathology form. Clin Transplant. 2017 Nov; 31(11).
    View on PubMed
  9. Orandi BJ, Luo X, King EA, Garonzik-Wang JM, Bae S, Montgomery RA, Stegall MD, Jordan SC, Oberholzer J, Dunn TB, Ratner LE, Kapur S, Pelletier RP, Roberts JP, Melcher ML, Singh P, Sudan DL, Posner MP, El-Amm JM, Shapiro R, Cooper M, Lipkowitz GS, Rees MA, Marsh CL, Sankari BR, Gerber DA, Nelson PW, Wellen J, Bozorgzadeh A, Osama Gaber A, Segev DL. Hospital readmissions following HLA-incompatible live donor kidney transplantation: A multi-center study. Am J Transplant. 2018 Mar; 18(3):650-658.
    View on PubMed
  10. Radhakrishnan K, Chi A, Quan DJ, Roberts JP, Terrault NA. Short Course of Postoperative Hepatitis B Immunoglobulin Plus Antivirals Prevents Reinfection of Liver Transplant Recipients. Transplantation. 2017 09; 101(9):2079-2082.
    View on PubMed
  11. Mehta N, Heimbach J, Lee D, Dodge JL, Harnois D, Burns J, Sanchez W, Roberts JP, Yao FY. Wait Time of Less Than 6 and Greater Than 18 Months Predicts Hepatocellular Carcinoma Recurrence After Liver Transplantation: Proposing a Wait Time "Sweet Spot". Transplantation. 2017 09; 101(9):2071-2078.
    View on PubMed
  12. Samoylova ML, Nigrini MJ, Dodge JL, Roberts JP. Biases in the reporting of hepatocellular carcinoma tumor sizes on the liver transplant waiting list. Hepatology. 2017 10; 66(4):1144-1150.
    View on PubMed
  13. Lai JC, Covinsky KE, Dodge JL, Boscardin WJ, Segev DL, Roberts JP, Feng S. Development of a novel frailty index to predict mortality in patients with end-stage liver disease. Hepatology. 2017 08; 66(2):564-574.
    View on PubMed
  14. Lewin SM, Mehta N, Kelley RK, Roberts JP, Yao FY, Brandman D. Liver transplantation recipients with nonalcoholic steatohepatitis have lower risk hepatocellular carcinoma. Liver Transpl. 2017 08; 23(8):1015-1022.
    View on PubMed
  15. Ge J, Roberts JP, Lai JC. Race/ethnicity is associated with ABO-nonidentical liver transplantation in the United States. Clin Transplant. 2017 Aug; 31(8).
    View on PubMed
  16. Salazar J, Saxena V, Kahn JG, Roberts JP, Mehta N, Volk M, Lai JC. Cost-Effectiveness of Direct-Acting Antiviral Treatment in Hepatitis C-Infected Liver Transplant Candidates With Compensated Cirrhosis and Hepatocellular Carcinoma. Transplantation. 2017 05; 101(5):1001-1008.
    View on PubMed
  17. Mehta N, Heimbach J, Harnois DM, Sapisochin G, Dodge JL, Lee D, Burns JM, Sanchez W, Greig PD, Grant DR, Roberts JP, Yao FY. Validation of a Risk Estimation of Tumor Recurrence After Transplant (RETREAT) Score for Hepatocellular Carcinoma Recurrence After Liver Transplant. JAMA Oncol. 2017 Apr 01; 3(4):493-500.
    View on PubMed
  18. Cai L, Yeh BM, Westphalen AC, Roberts J, Wang ZJ. 3D T2-weighted and Gd-EOB-DTPA-enhanced 3D T1-weighted MR cholangiography for evaluation of biliary anatomy in living liver donors. Abdom Radiol (NY). 2017 Mar; 42(3):842-850.
    View on PubMed
  19. Samoylova ML, Covinsky KE, Haftek M, Kuo S, Roberts JP, Lai JC. Disability in patients with end-stage liver disease: Results from the functional assessment in liver transplantation study. Liver Transpl. 2017 03; 23(3):292-298.
    View on PubMed
  20. Choi WT, Jen KY, Wang D, Tavakol M, Roberts JP, Gill RM. Donor Liver Small Droplet Macrovesicular Steatosis Is Associated With Increased Risk for Recipient Allograft Rejection. Am J Surg Pathol. 2017 Mar; 41(3):365-373.
    View on PubMed

Go to UCSF Profiles, powered by CTSI